A carregar...
Restraining CDK1–cyclin B activation: PP2A on the cUSP(7)
USP7 inhibitors are gaining momentum as a therapeutic strategy to stabilize p53 through their ability to induce MDM2 degradation. However, these inhibitors come with an unexpected p53‐independent toxicity, via an unknown mechanism. In this issue of The EMBO Journal, Galarreta et al report how inhibi...
Na minha lista:
| Publicado no: | EMBO J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8167361/ https://ncbi.nlm.nih.gov/pubmed/33969907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.2021108486 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|